ERBB2 and breast cancer: Traditionally, tumor grade, tumor size, lymph node status, estrogen (ER), progesterone (PgR), and human epidermal growth factor (HER2/neu or c-erbB2) receptor status have represented the main prognostic markers for BC [3].